NewsBenzingaCumberland Pharmaceuticals公布其口服伊非曲班用于系统性硬化症患者的2期ASSIST-SSc研究数据；胃肠道不良事件在伊非曲班组较安慰剂组更为常见；大多数患者表现出有限的疾病进展，这降低了追踪治疗差异的能力 Cumberland Pharmaceuticals公布其口服伊非曲班用于系统性硬化症患者的2期ASSIST-SSc研究数据；胃肠道不良事件在伊非曲班组较安慰剂组更为常见；大多数患者表现出有限的疾病进展，这降低了追踪治疗差异的能力 Benzinga 2026.10.23 20:09 (GMT+0) Open on Benzinga Other news Howard Hughes To Replace Arcosa In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On Wednesday, October 28 DA Davidson Maintains Buy on AppFolio, Raises Price Target to $250 Here’s How Much You Would Have Made Owning Palo Alto Networks Stock In The Last 10 Years DA Davidson Maintains Neutral on Pinnacle Finl Partners, Raises Price Target to $115 DA Davidson Maintains Neutral on Banner, Raises Price Target to $76 DA Davidson Maintains Neutral on Pool, Lowers Price Target to $200
Howard Hughes To Replace Arcosa In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On Wednesday, October 28
